Summary:
Interventional, randomized, double-blind, active-controlled study of the efficacy of Lu AF35700 in patients with early-in-disease or late-in-disease treatment-resistant schizophrenia
Qualified Participants Must:
• Between 18 and 65
•
Subject is an ambulatory man or woman
Qualified Participants May Receive:
Compensation for time and travel